Claudin 18.2 in cancer research and treatment: a pathologist’s perspective

克洛丹 免疫组织化学 医学 生物信息学 癌症 病理 下调和上调 紧密连接 生物标志物 癌症研究 临床意义 临床试验 活检 固定(群体遗传学) 肿瘤科 解剖病理学 克隆(Java方法) 生物 上皮 癌症生物标志物 转录因子
作者
Gurzhikhan Murtazaalieva,Angela Baldwin,Matteo Fassan,Vikram Deshpande
出处
期刊:Journal of Clinical Pathology [BMJ]
卷期号:: jcp-2025
标识
DOI:10.1136/jcp-2025-210328
摘要

Aims To provide a practical, pathology-centred overview of Claudin 18.2 as a biomarker and therapeutic target, covering biology, assay methods and interpretation, pre-analytical factors, clinicopathological associations and implications for treatment selection. Methods We performed a narrative review of the biomedical and pathology literature on CLDN18 /Claudin 18.2, including basic science, translational studies, immunohistochemistry (IHC) and in situ assays, and clinical trials of Claudin 18.2-directed therapies. Reference lists were hand-searched to capture additional relevant reports. Emphasis was placed on data informing routine diagnostic practice (expression patterns, scoring, fixation variables, pitfalls). Results Claudin 18.2 localises to tight junctions of differentiated gastric epithelium and is aberrantly expressed in gastric and gastro-oesophageal junction adenocarcinomas, with variable expression reported in pancreatic, biliary and other tumours. Loss or dysregulation of Claudin 18.2 contributes to tumour progression via disruption of epithelial integrity and activation of oncogenic pathways; infection-related and inflammation-related downregulation is described in gastric mucosa. For IHC, clone selection, tissue handling, fixation time and membrane-dominant scoring critically affect results; common pitfalls include cytoplasmic staining and heterogeneity. Claudin 18.2 expression shows predictive value for targeted agents under clinical use/evaluation, supporting its role as a companion biomarker. Reporting recommendations include membrane intensity/percentage thresholds and clear documentation of pre-analytical conditions. Conclusions Claudin 18.2 is a biologically plausible and clinically actionable biomarker. Robust pre-analytical handling, validated IHC protocols and standardised scoring are essential for reliable patient selection. Wider adoption of harmonised methods and further disease-specific studies will refine cut-offs, clarify prognostic value and optimise integration of Claudin 18.2-directed therapies into routine care.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Lucas的应助被斯文若血采纳,获得10
刚刚
刚刚
李健的小迷弟的应助被木子采纳,获得10
刚刚
李爱国的应助被www采纳,获得50
刚刚
星月发布了新的文献求助10
刚刚
1秒前
逢考必过完成签到,获得积分10
1秒前
优乐美完成签到,获得积分10
1秒前
纯情的阁发布了新的文献求助10
2秒前
纯情的阁发布了新的文献求助30
2秒前
2秒前
纯情的阁发布了新的文献求助10
2秒前
风吹麦浪的应助被司徒南瓜饼采纳,获得10
2秒前
2秒前
2秒前
纯情的阁发布了新的文献求助10
2秒前
纯情的阁发布了新的文献求助10
3秒前
4秒前
4秒前
5秒前
我是老大的应助被水水的采纳,获得10
5秒前
纯情的阁发布了新的文献求助100
5秒前
纯情的阁发布了新的文献求助10
5秒前
orixero的应助被亦禾子啊采纳,获得10
6秒前
NexusExplorer的应助被Zhupegnju采纳,获得10
6秒前
liao完成签到,获得积分10
7秒前
7秒前
7秒前
激情的怜晴完成签到,获得积分10
7秒前
夜子完成签到,获得积分10
8秒前
芝士完成签到 ,获得积分10
8秒前
米露完成签到 ,获得积分10
8秒前
纯情的阁发布了新的文献求助150
8秒前
隐形曼青的应助被孤独的冷安采纳,获得10
8秒前
烟花的应助被陆羽采纳,获得10
9秒前
纯情的阁发布了新的文献求助10
9秒前
纯情的阁发布了新的文献求助10
9秒前
陈陈完成签到 ,获得积分10
9秒前
daidai完成签到 ,获得积分10
9秒前
乐乐的应助被kj采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163922
求助须知:如何正确求助?哪些是违规求助? 9557995
关于积分的说明 21743022
捐赠科研通 7754548
什么是DOI,文献DOI怎么找? 3428401
关于科研通互助平台的介绍 2553053
邀请新用户注册赠送积分活动 2473008